Navigation Links
CorVel Announces Expanded Share Buyback
Date:9/17/2008

IRVINE, Calif., Sept. 17 /PRNewswire-FirstCall/ -- CorVel Corporation (Nasdaq: CRVL), reported that the Company's Board of Directors has approved a 1,000,000 share expansion to its existing stock repurchase plan, increasing the total number of shares approved for repurchase to 13,150,000.

CorVel commenced its share repurchase program in the fall of 1996. Since its inception through June 30, 2008, the Company has spent $166 million to repurchase 11,787,614 shares, equal to 46% of the outstanding common stock had there been no repurchases. These purchases have been funded primarily from net earnings. CorVel had 13,758,451 shares of common stock, net of treasury shares, outstanding as of June 30, 2008.

"CorVel continues to pursue expansion through both internal growth and acquisition. However, during periods when cash balances exceed internal needs, the Company will consider the repurchase of outstanding common stock," said Gordon Clemons, CorVel's Chairman.

The shares in the expanded repurchase program will be purchased from time to time at prevailing market prices, through open market or unsolicited negotiated transactions, depending upon market conditions. There is no guarantee as to the exact number of shares that will be repurchased by CorVel, and the Company may discontinue purchases at any time that management determines additional purchases are not warranted. The purchased shares will be used for general purposes, including issuance under the Company's stock option and stock purchase plans.

The Company also announced that pursuant to Board of Directors approval, the Company entered into a pre-arranged stock trading plan on September 16, 2008 to repurchase shares of its common stock. The stock trading plan
'/>"/>

SOURCE CorVel Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CorVel Announces Record Earnings
2. CorVel Announces Appearance at Bank of America Health Care Conference
3. CorVel to Present at UBS Global Healthcare Services Conference
4. CorVel Announces Record Earnings Per Share
5. CorVel Corporation Announces Resumption of Stock Repurchases
6. Lucas Group Announces Their Military Hiring Conferences Schedule for September
7. Integrative Nutrition Announces Partnership with SUNY
8. iMedica Announces Agreement with Misys
9. Rivulet Communications Announces New Technical Advisory Board and Initial Board Appointments
10. PA Governor Rendell Announces Nearly $750,000 Investment in Nurse Education
11. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...t;Preventing and Healing AIDS Through Our Inner Ph...S is a result of multiple, repeated and chronic ex...essor agents, which can be either chemical, physic... Oakland, CA (PRWEB) November...ogists, physicians, chemists and other scientists ...
(Date:11/8/2009)...pharmaceuticals to be available at the Company&rsq... Toronto, ON (PRWEB) November 8, 2009... Biopharma Inc. today announced that the Company h...ical grade freeze dryer and expects to make commer...e for contract manufacturing of biopharmaceuticals...
(Date:11/8/2009)...n the Western District of Pennsylvania award a Fay... for a medical malpractice case. Attorneys Thomas...s E. Crenney and Associates, LLC handled the case ...gainst the Uniontown Hospital. The woman had to h...ge 18. , Pittsburgh, PA(P...
(Date:11/8/2009)...s won," said Dr. Charmaine Yoest. ,, WASHINGTO...240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlkem...mandates and funding in HR 3962 passed on the Hous...esident and CEO Dr. Charmaine Yoest said, "The pas...fe Americans across this country who have flooded ...
(Date:11/8/2009)...e/ -- USAction this evening hailed passage of the ... make health care more affordable for consumers, h...ccess to health care for millions of Americans thr...and Harry Truman would be proud," said USAction Pr...mong our country,s proudest achievements. Today we...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...ve Website For Physically Able 50+ Adults To Promo...tyle , , CABOT, Vt., May 18 If you are age 50+,...ey of health and fitness that begins in the great ... Silver Fox, log on to Cabot,s Vermont To Fabulou...
...rating Officer Promotion , , FREMONT, Calif., May...: WGBS), a leading developer of state-of-the-art g...ppointments, naming Robert J. Hariri, M.D., Ph.D.,...life science industry experience, Drs. Hariri and ...
... support program designed to improve treatment out...illers or heroin, from Reckitt Benckiser Pharmaceu...ckiser Pharmaceuticals has launched Here to Help(...oxone HCl dihydrate [2 mg/0.5 mg and 8 mg/2 mg]) C...
...e Chance to Celebrate Dad and Give Back To A Worth...e 21, children will honor father figures in their ... wire service, is helping them score a home run w...o help raise awareness for prostate cancer and rai...
... IRVINE, Calif., May 18 /PRNewswire-FirstCall/ ...02) and IDM Pharma, Inc. (Nasdaq: IDMI ) today a...lly-owned subsidiary of Takeda (Takeda America), a... wholly-owned subsidiary to effect that transactio...
...th supplements product, helps slow and repair some...ns as we age , , MIAMI, May 18 RevGenetics annou...based telomere health supplements , Astral ...represent biomarkers of human aging and disease."*...
Other Medicine News:Health News:Cabot Creamery Cooperative's 'Vermont to Vegas' Online Health and Fitness Challenge is a Virtual Blast 2Health News:Cabot Creamery Cooperative's 'Vermont to Vegas' Online Health and Fitness Challenge is a Virtual Blast 3Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 2Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 3Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 4Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 5Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 2Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 3Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 4Health News:Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes 5Health News:Teleflora Hits it out of the Park With Flower Gifts for Father's Day 2Health News:Teleflora Hits it out of the Park With Flower Gifts for Father's Day 3Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 2Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 3Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 4Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 5Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 6Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 2Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 3Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 4
(Date:11/6/2009)...tCall/ -- Boston Scientific Corporation (NYSE: BS...nt in principle with the U.S. Department of Justic...s Guidant subsidiary in 2005. The alleged conduct...ific,s 2006 acquisition of Guidant. ,, Boston S...n by the U.S. Attorney,s Office in Minneapolis int...
(Date:11/6/2009)...l/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), a ...f small-molecule therapeutics for the treatment of...V), today reported recent accomplishments and fina...s ended September 30, 2009. ,, (Logo: http:/... ,, "Since our last quarterly update, we have c...
(Date:11/6/2009)... -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ...opharmaceutical company developing human vaccines ...cy Virus) and other infectious agents, today annou...provided an operational update. ,, Robert McNal...ommented, "We are pleased with our progress during...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 1Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 2Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 3Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 4Determining Who Will Respond to Brain Tumor Therapy 49802 1A Canada wide technology platform for mapping the human interactome 8974 1A Canada wide technology platform for mapping the human interactome 8974 2
...HINGTON, Oct. 22 Today, the American,Society of H...al Oncology,(ASCO) have released an updated joint ... agents (ESAs), a class of drugs that stimulate,th...treat,chemotherapy-related anemia., "One goal of ...most,up-to-date evidence from high-quality studies...
...ICIA, Calif., Oct. 22 AcroMetrix, the leading,pro...agnostic and blood,testing laboratories, announced...ntification Panel to be the first to utilize an ED...is for Research Use Only, not for use in,diagnosti... allows the OptiQuant HIV-1 panel to,most closely ...
Other Medicine Technology:ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 3AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel 2
Maverick Over-The-Wire 9 mm Catheter
CT100 Contact Tonometer
...ASURABLE ROI - Our networked solutions are deliver...cardiology. Never purchase software upgrades again...s to meet the ever-changing needs of your healthca...iology departments have a mix of old and new equip...
...X for Cardiology is the first digital solution des...us modalities both within and outside cardiology. ...chival solutions, Agfas combined expertise in both...r customers to work the way they want, wherever th...
Medicine Products: